» Articles » PMID: 10463582

Reciprocal Positive Regulation of Hypoxia-inducible Factor 1alpha and Insulin-like Growth Factor 2

Overview
Journal Cancer Res
Specialty Oncology
Date 1999 Aug 27
PMID 10463582
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia-inducible factor 1 (HIF-1) activates transcription of genes encoding glucose transporters, glycolytic enzymes, vascular endothelial growth factor, and other proteins involved in O2 homeostasis and tumor progression. The expression and transcriptional activity of the HIF-1alpha subunit is regulated by the cellular O2 concentration. We demonstrate that insulin, insulin-like growth factor (IGF)-1, and IGF-2 induce expression of HIF-1alpha, which is required for expression of genes encoding IGF-2, IGF-binding protein (IGFBP)-2 and IGFBP-3. These data provide a novel mechanism by which HIF-1alpha overexpression may occur in tumor cells and contribute to an autocrine growth factor loop.

Citing Articles

Hypoxia-inducible factor 1α is required to establish the larval glycolytic program in Drosophila melanogaster.

Heidarian Y, Fasteen T, Mungcal L, Buddika K, Mahmoudzadeh N, Nemkov T Mol Metab. 2025; 93:102106.

PMID: 39894213 PMC: 11869853. DOI: 10.1016/j.molmet.2025.102106.


Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy.

Antoniadou C, Gavriilidis E, Ritis K, Tsilingiris D Metabol Open. 2025; 25:100344.

PMID: 39886103 PMC: 11780985. DOI: 10.1016/j.metop.2024.100344.


Integration of Gastric Cancer RNA-Seq Datasets Along With PPI Network Suggests That Nonhub Nodes Have the Potential to Become Biomarkers.

Siavoshi A, Piran M, Sharifi-Zarchi A, Ataellahi F Cancer Rep (Hoboken). 2025; 8(1):e70126.

PMID: 39854135 PMC: 11757912. DOI: 10.1002/cnr2.70126.


Hypoxia-inducible factor 1α is required to establish the larval glycolytic program in .

Heidarian Y, Fasteen T, Mungcal L, Buddika K, Mahmoudzadeh N, Nemkov T bioRxiv. 2025; .

PMID: 39829828 PMC: 11741260. DOI: 10.1101/2025.01.07.631819.


IGFBP-2 in Critical Illness: A Prognostic Marker in the Growth Hormone/Insulin-like Growth Factor Axis.

Savvidis C, Kouroglou E, Kallistrou E, Ragia D, Dionysopoulou S, Gavriiloglou G Pathophysiology. 2024; 31(4):621-630.

PMID: 39585162 PMC: 11587456. DOI: 10.3390/pathophysiology31040045.